{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:49:39Z","timestamp":1791298179148,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Calcium"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ceca.2025.103107","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T16:50:16Z","timestamp":1766508616000},"page":"103107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Emerging therapeutics targeting the PI3K\/Akt\/GSK-3\u03b2 in calcium dysregulation in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"133","author":[{"given":"Simran","family":"Soni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ceca.2025.103107_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1459025","article-title":"The role of PI3K signaling pathway in Alzheimer\u2019s disease","volume":"16","author":"Pan","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ceca.2025.103107_bib0002","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.3390\/cimb45080393","article-title":"Alzheimer\u2019s Disease beyond calcium dysregulation: the complex interplay between calmodulin, calmodulin-binding proteins and amyloid beta from disease onset through progression","volume":"45","author":"O\u2019Day","year":"2023","journal-title":"Curr. Issues. Mol. Biol."},{"key":"10.1016\/j.ceca.2025.103107_bib0003","doi-asserted-by":"crossref","first-page":"313","DOI":"10.14283\/jpad.2021.15","article-title":"The epidemiology of Alzheimer\u2019s disease modifiable risk factors and prevention","volume":"8","author":"Zhang","year":"2021","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ceca.2025.103107_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1585711","article-title":"Global Burden of Alzheimer\u2019s disease and other dementias in adults aged 65 years and older, 1991\u20132021: population-based study","volume":"13","author":"Xiaopeng","year":"2025","journal-title":"Front. Public Health"},{"key":"10.1016\/j.ceca.2025.103107_bib0005","doi-asserted-by":"crossref","unstructured":"R. Landin-Romero, F. Kumfor, Letter re: neuropsychiatric symptoms predict hypometabolism in preclinical alzheimer disease, 2017. https:\/\/www.neurology.org.","DOI":"10.1212\/WNL.0000000000004591"},{"key":"10.1016\/j.ceca.2025.103107_bib0006","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/S0140-6736(13)60221-4","article-title":"Epidemiology of alzheimer\u2019s disease and other forms of dementia in China, 1990-2010: a systematic review and analysis","volume":"381","author":"Chan","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ceca.2025.103107_bib0007","first-page":"11","article-title":"Alzheimer\u2019s disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges","author":"Safiri","year":"2024","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.ceca.2025.103107_bib0008","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12213","article-title":"Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen","volume":"17","author":"Knopman","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.ceca.2025.103107_bib0009","doi-asserted-by":"crossref","unstructured":"Z.S. Khachaturian, Calcium hypothesis of Alzheimer\u2019s disease and brain aging a, 1994.","DOI":"10.1111\/j.1749-6632.1994.tb44398.x"},{"key":"10.1016\/j.ceca.2025.103107_bib0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1567205015666181022093359","article-title":"Astrocytic \u03b17 nicotinic receptor activation inhibits amyloid-\u03b2 aggregation by upregulating endogenous \u03b1b-crystallin through the PI3K\/Akt Signaling pathway","volume":"16","author":"Ren","year":"2018","journal-title":"Curr. Alzheimer. Res."},{"key":"10.1016\/j.ceca.2025.103107_bib0011","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/JAD-2012-120805","article-title":"Treatment of Alzheimer\u2019s disease with the GSK-3 inhibitor tideglusib: a pilot study","volume":"33","author":"Del Ser","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ceca.2025.103107_bib0012","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s12192-021-01231-3","article-title":"The PI3K\/Akt signaling axis in Alzheimer\u2019s disease: a valuable target to stimulate or suppress?","volume":"26","author":"Razani","year":"2021","journal-title":"Cell Stress. Chaperones."},{"key":"10.1016\/j.ceca.2025.103107_bib0013","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejphar.2014.06.051","article-title":"Downregulation of PI3K\/akt\/mTOR signaling pathway in curcumin-induced autophagy in APP\/PS1 double transgenic mice","volume":"740","author":"Wang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ceca.2025.103107_bib0014","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ceca.2025.103107_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001361","article-title":"Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan","volume":"8","author":"Yabe","year":"2020","journal-title":"BMJ Open. Diabetes. Res. Care"},{"key":"10.1016\/j.ceca.2025.103107_bib0016","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11064-012-0708-2","article-title":"Neuroinflammation and synaptic loss","volume":"37","author":"Rao","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ceca.2025.103107_bib0017","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.arr.2013.05.008","article-title":"Calcium dysregulation and neuroinflammation: discrete and integrated mechanisms for age-related synaptic dysfunction","volume":"12","author":"Sama","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ceca.2025.103107_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1347987","article-title":"The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets","volume":"16","author":"Adamu","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ceca.2025.103107_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1459025","article-title":"The role of PI3K signaling pathway in Alzheimer\u2019s disease","volume":"16","author":"Pan","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ceca.2025.103107_bib0020","article-title":"Spatial training preserves associative memory capacity with augmentation of dendrite ramification and spine generation in Tg2576 mice","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ceca.2025.103107_bib0021","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2217\/fnl.12.72","article-title":"A critical kinase cascade in neurological disorders: PI3K, akt and mTOR","volume":"7","author":"Chong","year":"2012","journal-title":"Future Neurol."},{"key":"10.1016\/j.ceca.2025.103107_bib0022","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-023-01324-1","article-title":"Neuroprotective effect of astragalin via activating PI3K\/akt-mTOR-mediated autophagy on APP\/PS1 mice","volume":"9","author":"Yang","year":"2023","journal-title":"Cell Death. Discov."},{"key":"10.1016\/j.ceca.2025.103107_bib0023","doi-asserted-by":"crossref","DOI":"10.1186\/s41983-023-00751-2","article-title":"Akt signaling pathway: a potential therapy for Alzheimer\u2019s disease through glycogen synthase kinase 3 beta inhibition","volume":"59","author":"Limantoro","year":"2023","journal-title":"Egypt. J. Neurol. Psychiatry Neurosurg."},{"key":"10.1016\/j.ceca.2025.103107_bib0024","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1007\/s00125-016-4102-5","article-title":"Sequential cleavage of insulin receptor by calpain 2 and \u03b3-secretase impairs insulin signalling","volume":"59","author":"Yuasa","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.ceca.2025.103107_bib0025","article-title":"Calcium dysregulation in Alzheimer\u2019s Disease: a target for new drug development","volume":"7","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis. Park."},{"key":"10.1016\/j.ceca.2025.103107_bib0026","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ceca.2025.103107_bib0027","first-page":"7","article-title":"NFATs and Alzheimer\u2019s Disease","volume":"2","author":"Abdul","year":"2010","journal-title":"Mol. Cell Pharmacol."},{"key":"10.1016\/j.ceca.2025.103107_bib0028","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1002\/jcp.27709","article-title":"GRK5 influences the phosphorylation of tau via GSK3\u03b2 and contributes to Alzheimer\u2019s disease","volume":"234","author":"Zhao","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.ceca.2025.103107_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084413","article-title":"Glycogen synthase kinase 3: ion channels, plasticity, and diseases","volume":"23","author":"Marosi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ceca.2025.103107_bib0030","article-title":"Truncation and activation of GSK-3\u03b2 by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer\u2019s disease","volume":"5","author":"Jin","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ceca.2025.103107_bib0031","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI64516","article-title":"Inhibition of GSK3\u03b2-mediated BACE1 expression reduces Alzheimer-associated phenotypes","volume":"123","author":"Ly","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ceca.2025.103107_bib0032","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci14060554","article-title":"Protein kinase C (PKC) in neurological health: implications for Alzheimer\u2019s disease and chronic alcohol consumption","volume":"14","author":"Singh","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.ceca.2025.103107_bib0033","doi-asserted-by":"crossref","first-page":"31337","DOI":"10.1016\/S0021-9258(19)84046-2","article-title":"Ca 2+ - and protein kinase C-dependent signaling pathway for nuclear factor-\u03bab activation, inducible nitric-oxide synthase expression, and tumor necrosis factor-\u03b1 production in lipopolysaccharide-stimulated rat peritoneal macrophages","volume":"281","author":"Zhou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2025.103107_bib0034","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.bbadis.2013.06.012","article-title":"Amyloid beta-induced glycogen synthase kinase 3\u03b2 phosphorylated VDAC1 in Alzheimer\u2019s disease: implications for synaptic dysfunction and neuronal damage","volume":"1832","author":"Reddy","year":"2013","journal-title":"Biochim. Biophys. Acta Mol. Basis. Dis."},{"key":"10.1016\/j.ceca.2025.103107_bib0035","article-title":"Truncation and activation of GSK-3\u03b2 by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer\u2019s disease","volume":"5","author":"Jin","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ceca.2025.103107_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/neuro.24.002.2009","article-title":"Susceptibility to calcium dysregulation during brain aging","volume":"1","author":"Kumar","year":"2009","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ceca.2025.103107_bib0037","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4161\/pri.21767","article-title":"Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia","author":"Berridge","year":"2013","journal-title":"Prion Landes Biosci."},{"key":"10.1016\/j.ceca.2025.103107_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112513","article-title":"Therapeutic strategies to target calcium dysregulation in Alzheimer\u2019s disease","volume":"9","author":"Calvo-Rodriguez","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ceca.2025.103107_bib0039","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3233\/JAD-160612","article-title":"Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons","volume":"57","author":"Rajmohan","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ceca.2025.103107_bib0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11813-6","article-title":"Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer\u2019s disease","volume":"10","author":"Jadiya","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ceca.2025.103107_bib0041","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s10495-009-0370-6","article-title":"An involvement of BDNF and PI3-K\/Akt in the anti-apoptotic effect of memantine on staurosporine-evoked cell death in primary cortical neurons","volume":"14","author":"Jantas","year":"2009","journal-title":"Apoptosis."},{"key":"10.1016\/j.ceca.2025.103107_bib0042","doi-asserted-by":"crossref","unstructured":"Y. Xu, Y.-W. Gao, Y. Yang, SC79 protects dopaminergic neurons from oxidative stress, 2018. www.impactjournals.com\/oncotarget.","DOI":"10.18632\/oncotarget.23538"},{"key":"10.1016\/j.ceca.2025.103107_bib0043","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3233\/JAD-171170","article-title":"Harpagoside rescues the memory impairments in chronic cerebral hypoperfusion rats by inhibiting PTEN activity","volume":"63","author":"Chen","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ceca.2025.103107_bib0044","article-title":"Relationship between adiponectin gene polymorphisms and late-onset Alzheimer\u2019s disease","volume":"10","author":"Yu","year":"2015","journal-title":"PLoS. One"},{"key":"10.1016\/j.ceca.2025.103107_bib0045","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/biof.1411","article-title":"Melatonin protects against A\u03b2-induced neurotoxicity in primary neurons via miR-132\/PTEN\/AKT\/FOXO3a pathway","volume":"44","author":"Zhao","year":"2018","journal-title":"Biofactors"},{"key":"10.1016\/j.ceca.2025.103107_bib0046","doi-asserted-by":"crossref","unstructured":"S. Akhondzadeh, M. Noroozian, M. Mohammadi, S. Ohadinia, A.H. Jamshidi Pharmd, M. Khani, Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer\u2019s disease: a double blind, randomized and placebo-controlled trial, 2003.","DOI":"10.1046\/j.1365-2710.2003.00463.x"},{"key":"10.1016\/j.ceca.2025.103107_bib0047","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/mp.2011.161","article-title":"Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3\u0392\/\u0392-catenin signaling","volume":"17","author":"Garza","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ceca.2025.103107_bib0048","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jep.2007.10.026","article-title":"Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia","volume":"115","author":"Zhang","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ceca.2025.103107_bib0049","doi-asserted-by":"crossref","first-page":"13138","DOI":"10.1523\/JNEUROSCI.4790-12.2013","article-title":"Arctigenin effectively ameliorates memory impairment in Alzheimer\u2019s disease model mice targeting both \u03b2-amyloid production and clearance","volume":"33","author":"Zhu","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ceca.2025.103107_bib0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jnc.13056","article-title":"Tripchlorolide improves cognitive deficits by reducing amyloid \u03b2 and upregulating synapse-related proteins in a transgenic model of Alzheimer\u2019s Disease","volume":"133","author":"Zeng","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ceca.2025.103107_bib0051","unstructured":"W. Chang, J. Teng, Original article \u03b2-asarone prevents A\u03b225-35-induced inflammatory responses and autophagy in SH-SY5Y cells: down expression beclin-1, LC3B and up expression bcl-2, 2015. www.ijcem.com\/."},{"key":"10.1016\/j.ceca.2025.103107_bib0052","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.physbeh.2017.07.023","article-title":"Silibinin ameliorates anxiety\/depression-like behaviors in amyloid \u03b2-treated rats by upregulating BDNF\/TrkB pathway and attenuating autophagy in hippocampus","volume":"179","author":"Song","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ceca.2025.103107_bib0053","doi-asserted-by":"crossref","DOI":"10.3390\/nu9080883","article-title":"Inhibitory effect of lycopene on amyloid-\u03b2-induced apoptosis in neuronal cells","volume":"9","author":"Hwang","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.ceca.2025.103107_bib0054","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3233\/JAD-180497","article-title":"Berberine alleviates tau hyperphosphorylation and axonopathy-associated with diabetic encephalopathy via restoring PI3K\/Akt\/GSK3\u03b2 pathway","volume":"65","author":"Wang","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ceca.2025.103107_bib0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11064-017-2421-7","article-title":"Resveratrol attenuates the cytotoxicity induced by amyloid-\u03b21\u201342 in PC12 cells by upregulating heme oxygenase-1 via the PI3K\/Akt\/Nrf2 pathway","volume":"43","author":"Hui","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ceca.2025.103107_bib0056","doi-asserted-by":"crossref","unstructured":"V. Stambolic, L. Ruel, J.R. Woodgett, Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells, 1996.","DOI":"10.1016\/S0960-9822(02)70790-2"},{"key":"10.1016\/j.ceca.2025.103107_bib0057","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41586-025-09335-x","article-title":"Lithium deficiency and the onset of Alzheimer\u2019s disease","volume":"645","author":"Aron","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ceca.2025.103107_bib0058","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.nbd.2010.03.022","article-title":"Indirubin-3\u2019-monoxime rescues spatial memory deficits and attenuates \u03b2-amyloid-associated neuropathology in a mouse model of Alzheimer\u2019s disease","volume":"39","author":"Ding","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ceca.2025.103107_bib0059","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2009.05.025","article-title":"A novel GSK-3\u03b2 inhibitor reduces Alzheimer\u2019s pathology and rescues neuronal loss in vivo","volume":"35","author":"Seren\u00f3","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ceca.2025.103107_bib0060","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI64516","article-title":"Inhibition of GSK3\u03b2-mediated BACE1 expression reduces Alzheimer-associated phenotypes","volume":"123","author":"Ly","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ceca.2025.103107_bib0061","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/jnc.12203","article-title":"AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans","volume":"125","author":"Georgievska","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ceca.2025.103107_bib0062","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/jnc.13254","article-title":"Activation of the phosphatidylinositol 3-kinase pathway plays important roles in reduction of cerebral infarction by cilnidipine","volume":"135","author":"Son","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ceca.2025.103107_bib0063","doi-asserted-by":"crossref","unstructured":"A. Macmanus, M. Ramsden, M. Murray, Z. Henderson, H.A. Pearson, V.A. Campbell, Enhancement of 45 Ca 2 influx and voltage-dependent Ca 2 channel activity by-amyloid-(1-40) in rat cortical synaptosomes and cultured cortical neurons MODULATION BY THE PROINFLAMMATORY CYTOKINE INTERLEUKIN-1*, 2000. http:\/\/www.jbc.org.","DOI":"10.1074\/jbc.275.7.4713"},{"key":"10.1016\/j.ceca.2025.103107_bib0064","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1471-4159.2006.03960.x","article-title":"Bis(7)-tacrine attenuates \u03b2 amyloid-induced neuronal apoptosis by regulating L-type calcium channels","volume":"98","author":"Fu","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ceca.2025.103107_bib0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1471-4159.2009.06297.x","article-title":"Cilnidipine mediates a neuroprotective effect by scavenging free radicals and activating the phosphatidylinositol 3-kinase pathway","volume":"111","author":"Lee","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ceca.2025.103107_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113210","article-title":"Cognitive improvement and synaptic deficit attenuation by a multifunctional carbazole-based cyanine in AD mice model through regulation of Ca2+\/CaMKII\/CREB signaling pathway","volume":"327","author":"Chen","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ceca.2025.103107_bib0067","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-05568-2","article-title":"Sodium\u2013calcium exchanger isoform-3 targeted Withania somnifera (L.) Dunal therapeutic intervention ameliorates cognition in the 5xFAD mouse model of Alzheimer\u2019s disease","volume":"12","author":"Afewerky","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ceca.2025.103107_bib0068","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuropharm.2010.07.013","article-title":"Calpain inhibition prevents amyloid-\u03b2-induced neurodegeneration and associated behavioral dysfunction in rats","volume":"59","author":"Granic","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ceca.2025.103107_bib0069","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3233\/JAD-200227","article-title":"Intranasal dantrolene as a disease-modifying drug in Alzheimer 5XFAD mice","volume":"76","author":"Shi","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ceca.2025.103107_bib0070","doi-asserted-by":"crossref","unstructured":"M. Popovic, M. Caballero-bleda, D. Bokonjic, S. Dobric, M. Popovid, Neuroprotective effect of chronic verapamil treatment on cognitive and noncognitive deficits In an experimental Alzheimer\u2019s disease In rats, 1997.","DOI":"10.3109\/00207459708986392"},{"key":"10.1016\/j.ceca.2025.103107_bib0071","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1016\/S0021-9258(19)70391-3","article-title":"The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain","volume":"255","author":"Hallcher","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2025.103107_bib0072","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-021-00036-1","article-title":"G-protein coupled receptor, PI3K and rho signaling pathways regulate the cascades of Tau and amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"2","author":"Desale","year":"2021","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.ceca.2025.103107_bib0073","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14818","article-title":"GSK3: a potential target and pending issues for treatment of Alzheimer\u2019s disease","volume":"30","author":"Zhao","year":"2024","journal-title":"CNS. Neurosci. Ther."},{"key":"10.1016\/j.ceca.2025.103107_bib0074","article-title":"DHCR24 Knock-down induced tau hyperphosphorylation at Thr181, Ser199, Thr231, Ser262, Ser396 epitopes and inhibition of autophagy by overactivation of GSK3\u03b2\/mTOR signaling","volume":"13","author":"Bai","year":"2021"},{"key":"10.1016\/j.ceca.2025.103107_bib0075","doi-asserted-by":"crossref","unstructured":"H. Xie, H. Wen, D. Zhang, L. Liu, B. Liu, Q. Liu, Q. Jin, K. Ke, M. Hu, X. Chen, Designing of dual inhibitors for GSK-3\u03b2 and CDK5: virtual screening and in vitro biological activities study, 2017. www.impactjournals.com\/oncotarget.","DOI":"10.18632\/oncotarget.15085"},{"key":"10.1016\/j.ceca.2025.103107_bib0076","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2011.00024","article-title":"Modulation of GSK-3 as a therapeutic strategy on tau pathologies","volume":"4","author":"Medina","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ceca.2025.103107_bib0077","doi-asserted-by":"crossref","unstructured":"D. Olivares, V.K. Deshpande, Y. Shi, D.K. Lahiri, N.H. Greig, J.T. Rogers, X. Huang, M. Lagos, N-Methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer\u2019s Disease, Vascular Dementia and Parkinson\u2019s Disease HHS Public Access, 2012. http:\/\/www.molgen.ua.ac.be\/ADMutations].","DOI":"10.2174\/156720512801322564"},{"key":"10.1016\/j.ceca.2025.103107_bib0078","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-4-14","article-title":"The PI3K-akt-mTOR pathway regulates a oligomer induced neuronal cell cycle events","volume":"4","author":"Bhaskar","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ceca.2025.103107_bib0079","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s12192-021-01231-3","article-title":"The PI3K\/Akt signaling axis in Alzheimer\u2019s disease: a valuable target to stimulate or suppress?","volume":"26","author":"Razani","year":"2021","journal-title":"Cell Stress. Chaperones."},{"key":"10.1016\/j.ceca.2025.103107_bib0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-023-01324-1","article-title":"Neuroprotective effect of astragalin via activating PI3K\/akt-mTOR-mediated autophagy on APP\/PS1 mice","volume":"9","author":"Yang","year":"2023","journal-title":"Cell Death. Discov."},{"key":"10.1016\/j.ceca.2025.103107_bib0081","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1097\/RLU.0000000000000547","article-title":"Brain PET in the diagnosis of Alzheimer\u2019s disease","volume":"39","author":"Marcus","year":"2014","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ceca.2025.103107_bib0082","article-title":"Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ceca.2025.103107_bib0083","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1693805","article-title":"The dual role of glycogen synthase kinase-3 beta (GSK3\u03b2) in neurodegenerative pathologies: interplay between autophagy and disease progression","volume":"16","author":"Alhassan","year":"2025","journal-title":"Front. Pharmacol."}],"container-title":["Cell Calcium"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143416025001150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143416025001150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:37:22Z","timestamp":1781462242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143416025001150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":83,"alternative-id":["S0143416025001150"],"URL":"https:\/\/doi.org\/10.1016\/j.ceca.2025.103107","relation":{},"ISSN":["0143-4160"],"issn-type":[{"value":"0143-4160","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging therapeutics targeting the PI3K\/Akt\/GSK-3\u03b2 in calcium dysregulation in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Cell Calcium","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ceca.2025.103107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103107"}}